About Sparsh Hospital & Critical Care
"Sparsh Hospitals and Critical Care is a well known brand in the health horizon of Odisha and has been instrumental in transforming the healthcare services in the state through its healing touch embedded with quality care, reasonable cost and desirable comfort. SPARSH brand has become an automatic reliable destination of healthcare not only for the people of Odisha but also for the neighborhood states through its committed caring services over last 13 years."
Clinical Trials at Sparsh Hospital & Critical Care
During the past decade, Sparsh Hospital & Critical Care conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Sparsh Hospital & Critical Care"
#1 collaborator was "Orion Corporation, Orion Pharma" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Sparsh Hospital & Critical Care
According to Clinical.Site data, the most researched conditions in "Sparsh Hospital & Critical Care" are
"Metastatic Colorectal Cancer" (1 trials) and "Prostatic Neoplasms" (1 trials). Many other conditions were trialed in "Sparsh Hospital & Critical Care" in a lesser frequency.
Clinical Trials Intervention Types at Sparsh Hospital & Critical Care
Most popular intervention types in "Sparsh Hospital & Critical Care" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Androgen deprivation therapy (ADT)" (1 trials), "Darolutamide (Nubeqa, BAY1841788)" (1 trials), "Placebo" (1 trials) and "Regorafenib (Stivarga, BAY73-4506)" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Sparsh Hospital & Critical Care
The vast majority of trials in "Sparsh Hospital & Critical Care" are
1 trials for "All" genders and 1 trials for "Male" genders.
Clinical Trials Status at Sparsh Hospital & Critical Care
Currently, there are NaN active trials in "Sparsh Hospital & Critical Care".
undefined are not yet recruiting,
undefined are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Sparsh Hospital & Critical Care,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Sparsh Hospital & Critical Care, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".